Worth reading
51Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Conditional
How definitive the wording is.Announced details
MEDiLiA (Medilia)MEDiLiA Shirotama Pure C ShotMEDiLiA Suikou ShotMEDiLiA LH-A ShotMEDiLiA P-DRN ShotMEDiLiA Azela Shot
Applicable field (uses covered by this announcement)
Daily skincareAt-home care following aesthetic treatments
Launch datePresales: 7 August 2026 (actual); full launch: scheduled for 14 September 2026; 2 additional products: scheduled for release this autumn
Offering price
Shirotama Pure C Shot: ¥3,190 / 28 sachets, ¥990 / 7 sachets (tax included)
Suikou Shot: ¥3,190 / 28 sachets, ¥990 / 7 sachets (tax included)
LH-A Shot: ¥1,980 / 14 sachets, ¥990 / 7 sachets (tax included)
P-DRN Shot: ¥2,970 / 28 sachets, ¥990 / 7 sachets (tax included)
Azela Shot: ¥2,970 / 28 sachets, ¥990 / 7 sachets (tax included)
The company does not address Contract Value / Impact on Business Performance.
| Item | Details |
|---|---|
| Names of Products / Services Covered | MEDiLiA (Medilia), MEDiLiA Shirotama Pure C Shot, MEDiLiA Suikou Shot, MEDiLiA LH-A Shot, MEDiLiA P-DRN Shot, MEDiLiA Azela Shot |
| Offering price | Shirotama Pure C Shot: ¥3,190 / 28 sachets, ¥990 / 7 sachets (tax included), Suikou Shot: ¥3,190 / 28 sachets, ¥990 / 7 sachets (tax included), LH-A Shot: ¥1,980 / 14 sachets, ¥990 / 7 sachets (tax included), P-DRN Shot: ¥2,970 / 28 sachets, ¥990 / 7 sachets (tax included), Azela Shot: ¥2,970 / 28 sachets, ¥990 / 7 sachets (tax included) |
| Launch date | Presales: 7 August 2026 (actual); full launch: scheduled for 14 September 2026; 2 additional products: scheduled for release this autumn |
| Applicable area | Daily skincare, At-home care following aesthetic treatments |
Items this document does not state (14)
CounterpartyCounterparty overviewRelationship with the CompanyContract ValueContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocationLocation scaleQuantitative EffectsUsage historyImpact on Business PerformanceSource
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To incorporate ingredients and concepts attracting attention in aesthetic treatments into everyday skincare and provide affordable products that customers can continue using.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.